The malaise theory of depression: Major depressive disorder is sickness behavior and antidepressants are analgesic

Medical Hypotheses

Volumn 54, Issue 1, 2000, Pages 126-130

  Charlton, B G ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CYTOKINE; FLUOXETINE; PHENELZINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ANALGESIA; CHRONIC PAIN; DEPRESSION; EMOTION; HUMAN; ILLNESS BEHAVIOR; PRIORITY JOURNAL; REVIEW; THEORY;

EID: 0034055445     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1054/mehy.1999.0986     Document Type: Article

References (27)

1. Healy D. Psychiatric Drugs Explained. 1996;Mosby-Wolfe, London.
2. Charlton B. G. Cognitive neuropsychiatry and the future of diagnosis. Br J Psychiatry. 167:1995;149-153.
3. Charlton B. G. Psychopharmacology and the human condition. JRSM. 91:1998;599-601.
4. Hart B. L. Biological basis of the behavior of sick animals. Neurosci Biobehav Rev. 12:1988;123-137.
5. Kent S., Bluthe R. -M., Kelly K. W., Dantzer R. Sickness behavior as a new target for drug development. Trends Pharmacol Sci. 12:1992;24-28.
6. Hickie I., Lloyd A. Are cytokines associated with neuropsychiatric syndromes in humans? Int J Immunopharmacol. 17:1995;677-683.
7. Yirmiya R. Behavioral and psychological effects of immune activation: implications for 'depression due to a general medical condition'. Curr Opin Psychiatry. 10:1997;470-476.
8. Maier S. F., Watkins L. R. Bidirectional communication between the brain and the immune system: implications for behavior. Animal Behav. 57:1999;741-751.
9. Healy D. The Suspended Revolution. 1990;Faber, London.
10. Smith A., Tyrrell D., Coyle K., Higgins P. Effects of interferon alpha on performance in man. Psychopharmacology. 96:1988;414-416.
11. Maes M., Bosmans E., Suy E. Depression-related disturbances in mitogen-induced lymphocyte responses, interleukin 1-beta, and soluble interleukin-2-receptor production. Acta Psychiatr Scand. 84:1991;379-386.
12. Joyce P. R., Hawes C. R., Mulder R. T., Sellman J. D., Wilson D. A., Boswell D. R. Elevated levels of acute phase plasma proteins in depression. Bio Psychiatry. 32:1992;1035-1041.
13. Maes M. A review on the acute phase response in major depression. Rev Neurosci. 4:1993;407-416.
14. Connor T. J., Leonard B. E. Depression, stress and immunological activation: the role of cytokines in depressive disorders. Life Sci. 62:1998;583-606.
15. Schneider K., Hamilton M. W., Anderson E. W. Clinical Psychopathology. 1959;Grune and Stratton, New York. p. 135-137.
16. Sims A. Symptoms in the Mind. 1995;WB Saunders, London.
17. Damasio A. R. Descartes, Error: Emotion, Reason and the Human Brain. 1994;Grosset/Putnam, New York.
18. Charlton B. G., Walston F. Individual case studies in clinical research. J Eval Clin Prac. 4:1998;147-155.
19. Charlton B. G. Theory of mind and the 'somatic marker mechanism' (SMM). Behav Brain Sci. 2000.
20. Charlton B. G., McClelland H. A. Theory of mind and the delusional disorders. J Nerv Ment Dis. 2000.
21. Lee R., Spencer P. S. J. Antidepressants and pain: a review of the pharmacological data supporting the use of certain tricyclics in chronic pain. J Internat Med Res. 5:1977;146-156.
22. Portnoy R. K., Kanner R. M. Pain Management: Theory and Practice. 1996;FA Davis, Philadephia. p. 226-229.
23. Xia Y., DePierre J. W., Nassberger L. Tricyclic antidepressants inhibit IL-6, IL-1beta and TNF-alpha release in human blood monocytes and IL-2 and interferon-gamma in T cells. Immunopharmacology. 34:1996;27-37.
24. Panerai A. E., Biachi M., Sacerdote P., Ripamonti C., Ventafridda V., De Conno F. Antidepressants in cancer pain. J Pall Care. 7:1991;42-44.
25. Holland J. C., Romano S. J., Heiligenstein J. H., Tepner R. G., Wilson M. G. A controlled trial of fluoxetine and desipramnine in depressed women with advanced cancer. Psychooncology. 7:1998;291-300.
26. McDaniel J. S., Musselman D. L., Porter M. R., Reed D. A., Nemeroff C. B. Depression in patients with cancer: diagnosis, biology and treatment. Arch Gen Psychiatry. 52:1995;89-99.
27. Muller H., Moller H. J. Methodological problems in the estimation of the onset of the antidepressant effect. J Affect Disord. 48:1998;15-23.